Pharmerica (PMC) Tops Q4 EPS by 4c; Guides FY16 EPS Below Expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
PharMerica Reports Fourth Quarter and Full Year 2015 Results
February 26, 2016 8:01 AM ESTSolid Sequential Improvement in Revenue, Gross Profit, Adjusted EBITDA and Adjusted Diluted Earnings Per Share
Announces Full Year 2016 Guidance
LOUISVILLE, Ky.--(BUSINESS WIRE)-- PharMerica Corporation (NYSE: PMC), a diversified national provider of institutional and specialty pharmacy services, today reported its financial results for the fourth quarter and full year ended December 31, 2015.
             4Q15 Results  ÂComparison to4Q14
 ÂComparison to3Q15
Revenue   $520.6 million   Decrease of 0.6%   Increase of 4.4%Adjusted EBITDA
... More